Past Lectures

Cancer Prevention and Control Colloquia Series
Date Speaker(s) Presentation Title
January 2022

Douglas Luke, Ph.D.
Brown School at Washington University in St. Louis

 Why is implementation so hard? A complex systems view of D&I Science
December 2021

Chanita Hughes-Halbert, Ph.D.
USC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA

 Translational Behavioral Science Research in Cancer Health Disparities
November 2021

Graham A. Colditz, M.D., Dr.P.H.
Chief, Division of Public Health Sciences at Washington University School of Medicine, St Louis, MO

 Addressing Breast Cancer Disparities in St Louis: From Population to Bench Science
November 2021

Cathy Bradley, Ph.D.
Associate Dean, Colorado School of Public Health, Deputy Director of the University of Colorado Cancer Center, Aurora, CO

 Cancer’s Financial Hardship: Opportunities for Policy and Practice
November 2021

Paul Han, M.D., M.A., M.P.H.
Senior Scientist, Behavioral Research Program (BRP), Division of Cancer Control and Population Sciences (DCCPS), National Cancer Institute, Rockville, MD

 Uncertainty in Cancer Prevention and Control: Needs and Challenges
October 2021

David C. Wheeler, Ph.D.
Associate Professor, Department of Biostatistics, VCU School Of Medicine, Richmond, VA

 Estimating Neighborhood Disadvantage Indices for Disease Risk
September 2021

Raymond Osarogiagbon, M.D.
Director of the Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, TN

 The Mid-South Miracle: A Program-Based Approach to Reducing Population-Level Lung Cancer Mortality
September 2021

Karen Basen-Engquist, Ph.D., M.P.H.
Annie Laurie Howard Research Distinguished Professor in the Department of Behavioral Science, Director of the Center for Energy Balance in Cancer Prevention and Survivorship, The University of Texas, MD Anderson Cancer Center

 Healthy Living After Cancer: Translating What We Know into What We Do
June 2021

Lisa Carter-Harris, Ph.D.
Memorial Sloan Kettering Cancer Center

 Beyond a Closed-Ended Question: Understanding the Decision to Screen or Not for Lung Cancer
May 2021

Jessica Scott, Ph.D.
Assistant Member, Exercise Oncology Service, Memorial Sloan Kettering Cancer Center

 From Spaceflight to Cancer Therapy: The Next Frontier of Multisystem Toxicity Countermeasures